Compare QTRX & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | HCAT |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Programming Data Processing |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 168.5M |
| IPO Year | 2017 | 2019 |
| Metric | QTRX | HCAT |
|---|---|---|
| Price | $3.71 | $2.08 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 10 |
| Target Price | ★ $6.00 | $2.53 |
| AVG Volume (30 Days) | 747.3K | ★ 1.3M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $37,632,000.00 | ★ $311,136,000.00 |
| Revenue This Year | $25.49 | N/A |
| Revenue Next Year | $10.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 64.52 | 1.48 |
| 52 Week Low | $2.40 | $0.96 |
| 52 Week High | $8.77 | $4.12 |
| Indicator | QTRX | HCAT |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 51.76 |
| Support Level | $3.30 | $2.02 |
| Resistance Level | $3.81 | $2.39 |
| Average True Range (ATR) | 0.32 | 0.10 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 9.37 | 13.16 |
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.